Somatropin biosimilar - Inbiopro Solutions
Alternative Names: IBPB 003HHLatest Information Update: 30 Oct 2021
At a glance
- Originator Inbiopro Solutions
- Class Growth hormones; Hormonal replacements; Obesity therapies; Proteins; Recombinant proteins
- Mechanism of Action Human growth hormone replacements
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Somatotropin deficiency
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for clinical-Phase-Unknown development in Somatotropin-deficiency(In children, In adults) in India
- 30 Jun 2012 Clinical trials in Somatotropin deficiency (childhood onset and adulthood onset) in India (unspecified route)